Cargando…

Hyperglycemia is a strong predictor of poor prognosis in COVID-19

AIMS: The objective of this study is to explore the association between documented diabetes, fasting plasma glucose (FPG), and the clinical outcomes of Coronavirus disease 2019 (COVID-19). METHODS: This retrospective study included 255 patients with COVID-19. Of these, 214 were admitted to isolation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Sheng-ping, Zhang, Qin, Wang, Wei, Zhang, Min, Liu, Chun, Xiao, Xuefei, Liu, Zongdao, Hu, Wen-mu, Jin, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377976/ https://www.ncbi.nlm.nih.gov/pubmed/32712122 http://dx.doi.org/10.1016/j.diabres.2020.108338

Ejemplares similares

ZFX is a Strong Predictor of Poor Prognosis in Renal Cell Carcinoma
por: Li, Changying, et al.
Publicado: (2015)

Low Hematocrit Is a Strong Predictor of Poor Prognosis in Lung Cancer Patients
por: Zhang, Xin, et al.
Publicado: (2018)

SKA3 Up-regulation Promotes Lung Adenocarcinoma Growth and is a Predictor of Poor Prognosis
por: Sun, Rong-Li, et al.
Publicado: (2019)

Coexpression of CMTM6 and PD-L1 as a predictor of poor prognosis in macrotrabecular-massive hepatocellular carcinoma
por: Liu, Li-Li, et al.
Publicado: (2020)

Is compromised intestinal barrier integrity responsible for the poor prognosis in critically ill patients with pre-existing hyperglycemia?
por: Wang, Yi-Feng, et al.
Publicado: (2022)

Phosphoglycerate dehydrogenase is a novel predictor for poor prognosis in gastric cancer
por: Xian, Yun, et al.
Publicado: (2016)

Upregulation of CENP-H in tongue cancer correlates with poor prognosis and progression
por: Liao, Wen-Ting, et al.
Publicado: (2009)

Low body mass index is an independent predictor of poor long-term prognosis among patients with resectable gastric cancer
por: Ma, Shuai, et al.
Publicado: (2021)

Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients
por: Zhang, Xiao-Fei, et al.
Publicado: (2016)

Association of stress hyperglycemia ratio and poor long-term prognosis in patients with myocardial infarction with non-obstructive coronary arteries
por: Abdu, Fuad A., et al.
Publicado: (2023)

Predictors of poor prognosis in patients with heat stroke
por: Chun, Jae-Kwon, et al.
Publicado: (2019)

The Loss of SMAD4/DPC4 Expression Associated with a Strongly Activated Hedgehog Signaling Pathway Predicts Poor Prognosis in Resected Pancreatic Cancer
por: Xu, Jin-Zhi, et al.
Publicado: (2019)

Erratum to Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients
por: Zhang, Xiao-Fei, et al.
Publicado: (2017)

Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer
por: Marx, Andreas, et al.
Publicado: (2021)

Amplification of the CD24 Gene Is an Independent Predictor for Poor Prognosis of Breast Cancer
por: Zhang, Peng, et al.
Publicado: (2019)

Hyperglycemia at admission is a strong predictor of mortality and severe/critical complications in COVID-19 patients: a meta-analysis
por: Yang, Yan, et al.
Publicado: (2021)

Increased LEF1 Expression and Decreased Notch2 Expression Are Strong Predictors of Poor Outcomes in Colorectal Cancer Patients
por: Wang, Wen-Juan, et al.
Publicado: (2013)

Increased Expression of CSF-1 Associates With Poor Prognosis of Patients With Gastric Cancer Undergoing Gastrectomy
por: Liu, Hao, et al.
Publicado: (2016)

BMP4, a strong better prognosis predictor, has a subtype preference and cell development association in gliomas
por: Bao, Zhaoshi, et al.
Publicado: (2013)

Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma()()
por: Fu, Jia, et al.
Publicado: (2015)

High expression of CHML predicts poor prognosis of multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2019)

FAT3 Mutation Is Associated With Tumor Mutation Burden and Poor Prognosis in Esophageal Cancer
por: Guo, Zixin, et al.
Publicado: (2021)

MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder
por: Zhu, Lin, et al.
Publicado: (2022)

High expression of ENPP2 is an independent predictor of poor prognosis in liver cancer
por: Meng, Jiyu, et al.
Publicado: (2023)

Low T3 syndrome is a strong predictor of poor outcomes in patients with community-acquired pneumonia
por: Liu, Jinliang, et al.
Publicado: (2016)

Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma
por: He, Fei, et al.
Publicado: (2015)

Decreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosis
por: Huang, Yan, et al.
Publicado: (2012)

Intestinal obstruction: predictor of poor prognosis in colorectal carcinoma?
por: Mohd Suan, Mohd Azri, et al.
Publicado: (2015)

High expression of eIF3d is associated with poor prognosis in patients with gastric cancer
por: He, Jiaqi, et al.
Publicado: (2017)

CD73 is associated with poor prognosis in HNSCC
por: Ren, Zhen-Hu, et al.
Publicado: (2016)

Long noncoding RNA GIHCG induces cancer progression and chemoresistance and indicates poor prognosis in colorectal cancer
por: Jiang, Xiaohua, et al.
Publicado: (2019)

High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis
por: Huang, Zhi-Liang, et al.
Publicado: (2015)

The stress hyperglycemia ratio is associated with the development of cerebral edema and poor functional outcome in patients with acute cerebral infarction
por: Deng, Yilun, et al.
Publicado: (2022)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

Capn4 overexpression indicates poor prognosis of ovarian cancer patients
por: Yang, Ming-Fang, et al.
Publicado: (2018)

ADAM12 is an independent predictor of poor prognosis in liver cancer
por: Du, Shuangqiu, et al.
Publicado: (2022)

High expression of UBE2T predicts poor prognosis and survival in multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2019)

Systemic Inflammation Response Index Is a Predictor of Poor Survival in Locally Advanced Nasopharyngeal Carcinoma: A Propensity Score Matching Study
por: Feng, Yuhua, et al.
Publicado: (2020)

Dysregulation of miR-138-5p/RPS6KA1-AP2M1 Is Associated With Poor Prognosis in AML
por: Yu, Dong-Hu, et al.
Publicado: (2021)

Interleukin-18 Is a Strong Predictor of Cardiovascular Events in Elderly Men With the Metabolic Syndrome: Synergistic effect of inflammation and hyperglycemia
por: Trøseid, Marius, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_b6gj0j81kh5da6k1bmivhedu87